Bank of America’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-43,156
Closed -$1.02M 8332
2023
Q4
$1.02M Sell
43,156
-15,472
-26% -$276K ﹤0.01% 4962
2023
Q3
$874K Sell
58,628
-123,091
-68% -$1.63M ﹤0.01% 4912
2023
Q2
$1.99M Sell
181,719
-343,974
-65% -$3.2M ﹤0.01% 4241
2023
Q1
$4.58M Buy
525,693
+417,851
+387% +$3.34M ﹤0.01% 3621
2022
Q4
$676K Buy
107,842
+35,066
+48% +$133K ﹤0.01% 5165
2022
Q3
$255K Sell
72,776
-51,033
-41% -$183K ﹤0.01% 5840
2022
Q2
$365K Buy
123,809
+49,333
+66% +$118K ﹤0.01% 5648
2022
Q1
$231K Sell
74,476
-11,989
-14% -$37.7K ﹤0.01% 6387
2021
Q4
$292K Sell
86,465
-18,722
-18% -$71.1K ﹤0.01% 6261
2021
Q3
$384K Buy
105,187
+14,440
+16% +$56.9K ﹤0.01% 5838
2021
Q2
$396K Sell
90,747
-22,454
-20% -$99.5K ﹤0.01% 5606
2021
Q1
$514K Buy
113,201
+64,684
+133% +$348K ﹤0.01% 5340
2020
Q4
$279K Buy
48,517
+38,933
+406% +$295K ﹤0.01% 5383
2020
Q3
$69K Sell
9,584
-322,504
-97% -$1.72M ﹤0.01% 5868
2020
Q2
$1.16M Sell
332,088
-42,170
-11% -$122K ﹤0.01% 4020
2020
Q1
$553K Buy
374,258
+312,860
+510% +$525K ﹤0.01% 4441
2019
Q4
$120K Sell
61,398
-156,233
-72% -$587K ﹤0.01% 5915
2019
Q3
$1.11M Sell
217,631
-10,117
-4% -$61.2K ﹤0.01% 4484
2019
Q2
$1.63M Buy
227,748
+37,862
+20% +$429K ﹤0.01% 4202
2019
Q1
$2.52M Buy
189,886
+25,694
+16% +$273K ﹤0.01% 3806
2018
Q4
$1.29M Buy
164,192
+2,478
+2% +$23.6K ﹤0.01% 4211
2018
Q3
$1.79M Buy
161,714
+151,912
+1,550% +$1.89M ﹤0.01% 4067
2018
Q2
$131K Sell
9,802
-5,265
-35% -$65.9K ﹤0.01% 5655
2018
Q1
$196K Buy
+15,067
New +$187K ﹤0.01% 5375
2017
Q1
Sell
-1
Closed 7306
2016
Q4
$0 Sell
1
-414
-100% -$731 ﹤0.01% 7398
2016
Q3
$1K Buy
415
+339
+446% +$674 ﹤0.01% 6988
2016
Q2
$0 Sell
76
-2,124
-97% -$4.41K ﹤0.01% 7467
2016
Q1
$3K Hold
2,200
﹤0.01% 6717
2015
Q4
$4K Hold
2,200
﹤0.01% 6962
2015
Q3
$4K Hold
2,200
﹤0.01% 6845
2015
Q2
$6K Buy
+2,200
New +$9.04K ﹤0.01% 6773

Other funds holding CBAY